Syphilis iridocyclitis in a patient with type 1 diabetes by Comassi M et al.
Syphilis iridocyclitis in a patient with type 1
diabetes
Mario Comassi, Andrea Natali, Anna Solini*
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Keywords
Iridocyclitis, Syphilis, Type 1 diabetes
*Correspondence
Anna Solini
Tel.: +39-050993482
Fax: +39-050553235
E-mail address: anna.solini@med.unipi.it
J Diabetes Investig 2016; 7: 641–644
doi: 10.1111/jdi.12447
ABSTRACT
We present a rare cause of iridocyclitis in a patient with vitiligo and type 1 diabetes who
showed poor metabolic control, and suffered from remitting fever, weight loss, fatigue, dif-
fuse arthralgias and reduced visual acuity. Mild systemic symptoms coupled with increased
cholestasis enzymes, insulin resistance, mild inflammation and a functioning adrenal gland
focused our clinical work-up on granulomatous causes of iridocyclitis. Specific tests con-
firmed syphilis, with no involvement of the central nervous system. Ocular syphilis, despite
being unusual, can be the only manifestation of the disease. The work-up of any
unexplained ocular inflammation should include testing for syphilis so as to not delay the
diagnosis.
INTRODUCTION
Ocular involvement is common in autoimmune disorders; con-
versely, patients with autoimmune polyglandular syndrome
(APS) frequently show vitiligo, alopecia, pernicious anemia,
chronic hepatitis and uveitis1,2. Transgenic mice deficient for
the autoimmune regulator gene develop type 1 APS and uvei-
tis3. Therefore, searching for other autoimmunity diseases is
mandatory in the clinical suspect of APS.
The combination of type 1 diabetes, vitiligo, thyroid disor-
ders and adrenal insufficiency suggests the presence of type 2
APS4; other combinations of organ-specific autoimmune disease
are compatible with type 3 or type 4 APS; however, the
autoimmune disease might occur progressively within a wide
age span, making the diagnosis difficult. With all this in mind,
we suspected an autoimmune origin of iridocyclitis that devel-
oped in a patient with vitiligo, type 1 diabetes, alopecia and
thyroid disease.
CASE REPORT
A 61-year-old man with type 1 diabetes and long-lasting poor
metabolic control (glycated hemoglobin 100 mmol/mol, 11.3%)
despite a 96-IU basal–bolus insulin regimen was referred to our
clinic at the Department of Clinical and Experimental Medicine
University of Pisa, Pisa, Italy. His clinical history showed viti-
ligo, a previous hyperthyroidism corrected with methimazole, a
cholecystectomy for gall bladder stones and a prior diagnosis of
chronic obstructive pulmonary disease.
At the age of 43 years, after a sudden retinal detachment in
the left eye, diabetes was diagnosed; insulin therapy was started
without further characterization of the disease.
Four months before coming to our attention, the patient suf-
fered for 2 months from a remittent fever (38.5°C), not associ-
ated with shivering, and weight loss (-10%); routine blood tests
were normal except for mild abnormalities in aspartate amino-
transferase, alanine aminotransferase, c-glutamyl transferase
and alkaline phosphatase. Then he developed a progressive
reduction of visual acuity in the right eye; an iridocyclitis was
diagnosed, whose etiology was not investigated. He also
reported unstable glycemic control, requiring a significant
increase in total daily insulin dose, associated with weight loss,
fatigue, diffuse arthralgias persisting throughout the day and
declining during the night, and sporadic recurrence of mild
fever (37–37.5°C).
Clinical examination
The patient was hemodynamically stable. His skin showed signs
of segmental vitiligo. His head showed sparse alopecia. An eye
examination found bilateral mild miosis with a turbid right iris,
and depigmented redness around the cornea and conjunctiva.
His thyroid was palpable, with small nodules. Cardiac action
was eurhythmic, with no murmurs. A chest examination found
kyphosis with sounds of bronchoconstriction. His abdomen
was not painful; there was no appreciable liver and spleen
enlargement. His genitourinary system showed nothing
remarkable. There was no peripheral edema. A neurological
examination was normal, apart from a reduction of visual acu-
ity in the right eye.Received 19 June 2015; revised 28 October 2015; accepted 8 November 2015
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Biochemical parameters
Complete blood count, C-reactive protein, international normal-
ized ratio, activated partial thromboplastin time, blood urea
nitrogen, creatinine, uric acid, total protein, bilirubin, lipid pro-
file, creatine kinase, pancreatic amylase and lipase showed nor-
mal values. The patient was negative for hepatitis B virus,
hepatitis C virus and HIV. Anti-mitochondrial antibodies, anti-
smooth muscle antibodies, anti-neutrophil cytoplasmic antibod-
ies, extractable nuclear antigens, anti-liver kidney microsomal
antibodies, scleroderma-70 kD extractable immunoreactive frag-
ment antibodies, rheumatoid arthritis test, anti-tissue transglu-
taminase antibodies, endomysial antibodies, deamidated gliadin
peptide antibodies and hormones (thyroid-stimulating
hormone, free tri-iodothyronine, free thyroxine, adrenocorti-
cotrophic hormone, cortisol, luteinizing hormone, follicle-stimu-
lating hormone, free testosterone, growth hormone, prolactin,
parathyroid hormone) were all normal, as well as thyroid
autoantibodies (anti-thyroglobulin autoantibodies and anti-thyr-
oid peroxidase autoantibodies: <1 IU/mL for both). A slight
positivity of anti-surrenal gland antibodies was evident.
Gamma-glutamyl transferase (115 U/L; normal value <60),
alkaline phosphatase (194 U/L; <115) and erythrocytes
sedimentation rate (38 mm/h) showed altered values.
The presence of glutamic acid decarboxylase and tyrosine
phosphatase-like protein IA2 antibodies with undetectable C-
peptide confirmed type 1 diabetes. Despite insulin uptitration,
glucose values were extremely variable, with mild hypoglycemic
episodes and frequent, severe hyperglycemia. Common causes
of poor glycemic control, including neoplasms, were excluded.
The combination of vitiligo, alopecia, type 1 diabetes, previous
hyperthyroidism and the presence of positive adrenal antibod-
ies allowed the suspicion of type 2 APS, but adrenal function
was normal. Therefore, low-grade fever, fatigue and weight loss,
increased cholestasis enzymes, insulin resistance, and mild
inflammation focused our clinical work-up on the granuloma-
tous causes of iridocyclitis: the sexual habits of the patient were
investigated; treponemal screening was 40.95 S/CO (normal
value <1.0) and a treponemal test found: Treponema pallidum
hemoagglutination assay >1:40960, immunoglobulin G and
immunoglobulin M positivity for Treponema pallidum, and flu-
orescent treponemal antibody absorption positive 3+/4+.
Although international guidelines for treatment suggest
penicillin-G as the first-choice drug for the treatment of all
stages of syphilis5, we started with ceftriaxone and doxycy-
cline, continuing at home with benzathine penicillin (four
intramuscular doses of 2.4 MU each at 1-week interval).
Immediately after the first dose of ceftriaxone and doxycy-
cline, the patient developed a Jarish–Herxheimer reaction (as
a result of a massive release of treponemal antigens); however,
in the light of such a reaction and in order to prevent a pos-
sible worsening of the ocular manifestations, i.v. methylpred-
nisolone had been administered before starting antimicrobial
therapy.
To investigate central nervous system involvement, brain
magnetic resonance imaging was carried out (signs of a previ-
ous optic neuritis). Lumbar puncture was postponed, as the
patient was HIV-negative and iridocyclitis was the only neuro-
logical manifestation of the disease.
During the follow up, the patient reported subjective well-
being with rapid improvement of visual acuity and eye inflam-
mation (Figure 1). Glycemic control, though still suboptimal,
was obtained with a total of 58 IU of insulin. Six months after
the diagnosis, Treponema pallidum hemoagglutination assay
was 1:10240 and venereal disease research laboratory 1:16.
DISCUSSION
Despite the presence of a clinical phenotype suggestive of APS,
the nature of this iridocyclitis was not related to the autoim-
mune disorder. Acute anterior uveitis can be idiopathic, some-
times HLA-B27-linked or granulomatous, the latter either
associated with systemic infectious processes, such syphilis,
Lyme disease, tuberculosis or herpetic viral infections, or sar-
coidosis. In this perspective, specific serology tests should be
arranged in case of intractable uveitis of uncertain origin, espe-
cially in HIV patients, where macular palcoid chorioretinitis
can occur6.
In Italy, 720 cases of syphilis were recorded in the National
Health Registry in 2007; 78% occurred in male subjects.
According to 2011 World Health Organization data, the esti-
mated number of new cases of curable sexually transmitted dis-
eases in adults, in Europe, is 20 million, of which, in 2010,
17,884 were cases of syphilis7. In the post-war period, a rela-
tionship between syphilis and diabetes was described; recently,
an increased prevalence of type 2 diabetes has been reported
among patients with neurosyphilis; these patients were also
characterized by a worse metabolic pattern, with higher fasting
glucose and glycated hemoglobin levels8.
Ocular manifestation of syphilis can occur at any stage of
the disease, mimic a wide range of ocular disorders, and lead
to misdiagnoses and delay in the administration of appropriate
antimicrobial therapy. Syphilis is a rare cause of uveitis; it
might occur 6 weeks after primary infection, sometimes being
the only systemic sign of secondary syphilis, often characterized
by optic neuropathy.
The diagnosis of syphilis in the present patient was, in fact,
delayed; a meditated interpretation of the clinical history and a
critically-oriented analysis of laboratory tests would have
allowed us to rapidly formulate a correct diagnosis. In fact, as
early as 4 months before coming to our attention, the patient
started to report symptoms not clearly related to a rise in the
hepatobiliary indices in a long term-cholecystectomized individ-
ual. Therefore, a screening for hepatotropic viruses, syphilis and
HIV should had been carried out even at that time, because of
the presence of risk behaviors. When iridocyclitis developed, it
was considered an autoimmune epiphenomenon of a coexisting
APS, with this view being supported by the low-grade inflam-
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mation and the worsening glycemic control. Such a hypothesis
allowed us to also explain flu-like symptoms and fever; on the
same basis, the suspicion of syphilitic etiology could have been
made previously. We attributed the modest rise in liver
enzymes to hepatosteatosis, likely worsened by the metabolic
and inflammatory derangement. However, it is good practice,
when there is an increase in transaminases or cholestasis
indexes in the absence of hepatitis or hepatobiliary disease, to
carry out screening tests for syphilis, given that various degrees
of hepatobiliary involvement are reported in early and late
stages of syphilis9,10. An attempt to correctly define the patient’s
phenotype, even in the presence of an atypical presentation of
the disease (Figure 2), is of particular relevance in a perspective
of prevention and early treatment aiming at reducing severe
complications and improving the prognosis.
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Figure 2 | The natural history of syphilis in the patient. CNS, central nervous system.
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Figure 1 | The (a) eyes status and (b) vitiligo (detail of the hands) 4 months after the diagnosis.
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